Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

ClinicalTrials.gov ID: NCT07665437

Public ClinicalTrials.gov record NCT07665437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 17, 2026, 12:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Double-dummy, Parallel Group, Multicenter Phase 3 Extension Study Evaluating the Long-term Safety and Efficacy of 2 Doses of Remibrutinib in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the long-term safety, tolerability and efficacy of remibrutinib (LOU064) in adult participants with moderate to severe hidradenitis suppurativa (HS) who have completed either of the preceding Phase 3 studies, CLOU064J12301 or CLOU064J12302.

Study identification

NCT ID
NCT07665437
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
710 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 10, 2026 (Actual)
Primary completion
Oct 29, 2031 (Estimated)
Completion
Oct 29, 2031 (Estimated)
Last update posted
Oct 13, 2026

2026 – 2031

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Total Skin and Beauty Dermatology Center PC Birmingham Alabama 35205 Recruiting
Johnson Dermatology Fort Smith Arkansas 72916 Recruiting
Arkansas Research Trials North Little Rock Arkansas 72117 Recruiting
Ctr for Dermatology Clinical Res Fremont California 95438 Recruiting
USC Keck School of Medicine Los Angeles California 90033 Recruiting
Olive View UCLA Medical Center Sylmar California 91342 Recruiting
Clinical Trials Research Institute Thousand Oaks California 91320 Recruiting
Floridian Research Institute Miami Florida 33179 Recruiting
University Of South Florida Tampa Florida 33612 Recruiting
Endeavor Health Glenview Illinois 60077 Recruiting
Dundee Dermatology West Dundee Illinois 60118 Recruiting
Southern IN Clinical Trials New Albany Indiana 47150 Recruiting
Skin Specialists PC Omaha Nebraska 68144 Recruiting
Cameron Dermatology New York New York 10023 Recruiting
Icahn School Of Med At Mount Sinai New York New York 10029 Recruiting
OnSite Clinical Solutions LLC Huntersville North Carolina 28078 Recruiting
Optima Research Boardman Boardman Ohio 44512 Recruiting
Apex Clinical Research Center LLC Mayfield Heights Ohio 44124 Recruiting
UP Medical Center H System Pittsburgh Pennsylvania 15213-3403 Recruiting
Clinical Research Ctr of Carolinas Charleston South Carolina 29407 Recruiting
Center for Clinical Studies-Lee Webster Texas 77598 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07665437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07665437 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →